Cải thiện chất lượng và chi phí trong việc kê đơn cho trẻ sơ sinh thông qua kiểm tra lâm sàng

Bernard, P.A. (1981), “Freedom from ototoxicity in aminoglycoside treated neonates: a mistaken notion”, Laryngoscope, Vol. 91, pp. 1985‐94. Borradori, C., Fawer, C.L., Buclin, T. and Calame, A. (1997), “Risk factors of sensorineural hearing loss in preterm infants”, Biology of the Neonate, Vol. 71, pp. 1‐10. BMJ Publications (2001), Northern Neonatal Pharmacopoeia, BMJ Publications, London. Chayasirirsobhon, S., Yu, L., Griggs, L., Westmoreland, S.J. and Leu, N. (1996), “Reducing of brain stem evoked potentials and their association with gentamicin in neonates”, Pedaitric Neurology, Vol. 14, pp. 277‐80. Davies, M.W. and Cartwright, D.W. (1998), “Gentamicin dosage interval in neonates: longer dosage interval‐less toxicity”, Journal of Pediatrics and Child Health, Vol. 34 No. 6, pp. 577‐80. de Hoog, M., Mouton, J.W. and van den Anker, J.N. (1998),“The use of aminoglycosides in newborn infants”, Paediatric and Perinatal Drug Therapy, Vol. 1, pp. 48‐56. de Man, P., Verhoeven, B.A., Verbrugh, H.A., Vos, M.C. and van den Anker, J.N. (2000), “An antibiotic policy to prevent emergence of resistant bacilli”, Lancet, Vol. 355 No. 9208, pp. 973‐8. Drugs and Therapeutics Bulletin (1997), “Aminoglycosides once daily?”, Drugs and Therapeutics Bulletin, Vol. 35 No. 5, pp. 36‐7. Fisman, D.N. and Kaye, K.M. (2000), “Once daily dosing of aminoglycoside antibiotics”, Infectious Disease Clinics of North America, Vol. 14 No. 2, pp. 475‐87. Gooding, N., Elias‐Jones, A. and Shenoy, M. (2001), “Gentamicin dosing in neonatal patients”, Pharmacy World Science, Vol. 23 No. 5, pp. 179‐80. Grant, L. and Macdonald, P. (2001), “Medicines for children and gentamicin toxicity”, Archives of Diseases in Childhood, Vol. 85 No. 1, p. 79. Hayani, K.C., Hatzopolous, F.K., Frank, A.L., Thummala, M.R., Hantsch, M.J., Schatz, B.M., John, E.G. and Vidyasagar, D. (1997), “Pharmacokinetics of once‐daily dosing of gentamicin in neonates”, Journal of Pediatrics, Vol. 131 No. 1, pp. 76‐80. Hitt, C., Klepser, M., Nightingale, C., Qunitiliani, R. and Nicolau, D.P. (1997), “Pharmacoeconomic impact of once‐daily aminoglycoside administration”, Pharmacotherapy, Vol. 17 No. 40, pp. 810‐4. Keyes, P.S., Johnson, C.K. and Rawlins, T.D. (1989), “Predictors of trough serum gentamicin concentrations in neonates”, American Journal of Diseases in Children, Vol. 143, pp. 1419‐23. Krishnan, L. and George, S.A. (1997), “Gentamicin therapy in preterms: a comparison of two dosage regimens”, Indian Pediatrics, Vol. 34 No. 12, pp. 1075‐80. Langlass, T.M. and Mickle, T.R. (1999), “Standard gentamicin dosage regimen in neonates”, American Journal of Health System Pharmacy, Vol. 56 No. 5, pp. 440‐3. Lesko, S.M., Epstein, M.F. and Mitchell, A.A. (1990), “Recent patterns of drug use in newborn intensive care”, Journal of Pediatrics, Vol. 116, pp. 985‐90. Lundergan, F.S., Glasscock, G.F., Kim, E.H. and Cohen, R.S. (1999), “Once daily gentamicin dosing in newborn infants”, Pediatrics, Vol. 103 No. 60, pp. 1228‐34. Miron, D. (2001), “Once‐daily dosing of gentamicin in infants and children”, Pediatric Infectious Diseases Journal, Vol. 20 No. 12, pp. 1169‐73. Ohler, K.H., Menke, J.A. and Fuller, L. (2000), “Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit”, American Journal of Perinatology, Vol. 17 No. 6, pp. 285‐90. Paap, C.M. and Nahata, M.C. (1990), “Clinical pharmacokinetics of antibacterial drugs in neonates”, Clinical Pharmacokinetics, Vol. 19, pp. 280‐318. RCPCH Publications Limited (1999), Medicines for Children, RCPCH Publications Limited, London. Stickland, M.D., Kirkpatrick, C.M., Begg, E.J., Duffull, S.B., EdIie, S.J. and Darlow, B.A. (2001), “An extended interval dosing method for gentamicin in neonates”, Journal of Antimicrobial Chemotherapy, Vol. 48 No. 6, pp. 887‐93. Taddio, A. (1998), “Is there evidence for routine TDM in paediatric patients?”, Bailliere's Clinical Paediatrics, Vol. 6 No. 3, pp. 353‐76. Thureen, P.J., Reiter, P.D., Gresores, A., Stolpman, N.M., Kawato, K. and Hall, D.M. (1999), “Once‐ versus twice‐daily gentamicin dosing in neonates >34 weeks’ gestation: cost‐effectiveness analysis”, Pediatrics, Vol. 103 No. 3, pp. 594‐8. Zaske, D.E. (1992), “Aminoglycosides”, in Evans, W.E., Schentag, J. and Jusko, W. (Eds), Applied Pharmacokinetics: Principles of TDM, Applied Theapeutics, Inc., Vancouver, pp. 14‐39.